Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Novel contraceptive agents imparted by Pharmacopeia

Oct. 3, 2007

Phase II studies commence for PYY3-36 nasal spray to treat obesity

Oct. 3, 2007

Minodronate effective in Japanese women with postmenopausal osteoporosis

Oct. 3, 2007

EC expands indication of Amgen's Aranesp

Oct. 2, 2007

Preclinical results of VEL-0230, a dual-action cathepsin K inhibitor, reported

Oct. 2, 2007

Palatin provides update on phase II trial of bremelanotide for FSAD

Oct. 2, 2007

OctoPlus acquires worldwide rights to Theratechnologies' GLP-1 analogues

Oct. 2, 2007

Study reveals advantages of insulin VIAject over insulin lispro, regular insulin

Oct. 2, 2007

Novartis' Galvus approved in combination with oral antidiabetes medicines in Europe

Oct. 1, 2007

EMEA recommends amendment to prescribing information for ESAs in the E.U.

Oct. 1, 2007

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 15, 2026.
ASGCT 2026: Circular RNA, the new beast in gene and cell therapy
BioWorld
Circular RNA (circRNA) is not a new concept, but it is a novel strategy in the field of gene and cell therapy. While mRNA vaccines have revolutionized medicine,...
Advancing the 'best of both' – BMS, Hengrui enter $15.2B deal
BioWorld
In a deal potentially worth up to $15.2 billion, Jiangsu Hengrui Pharmaceuticals Co. Ltd. is joining efforts with Bristol Myers Squibb Co. to advance 13 early...
News in brief
BioWorld Asia
BioWorld Asia briefs for May 12, 2026
ASGCT 2026: Uncovering the mechanisms of AAV toxicity
BioWorld
Gene therapies rely on vectors to reach the target tissue where they act, such as adeno-associated viruses (AAVs) or lipid nanoparticles (LNPs), among other...